Αποτελέσματα Αναζήτησης
4 ημέρες πριν · MPM BioImpact | Home. We create and invest in biotech companies with innovative technologies that are developing life-saving drugs for patients. We invest in both private and public companies, providing a unique longitudinal view of drug development across the industry.
Learn more about MPM’s expert team of entrepreneurs with deep domain expertise in research and development, intellectual property, clinical strategy and commercialization.
MPM BioImpact combines the 30+ year track record of the MPM CAPITAL ® services and offerings in biotech venture capital with BioImpact’s dedication to impact and 10+ years of experience in public investing. Together, we manage over $3 billion AUM across early-stage venture funds, private/public impact funds and a public equities fund.
MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures...
Founded in 1997, MPM Capital is a venture capital investment firm based in Boston, Massachusetts. The firm prefers to invest in the biotechnology, healthcare, and life sciences sectors in the United States. This firm is a Registered Investment Adviser (RIA). Business Details. Website. www.mpmbioimpact.com. Formerly Known As.
13 Απρ 2021 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--MPM Capital (MPM), a biotechnology investment firm investing in early-stage therapeutics companies, today announced that Pankaj Bhargava, MD has joined...
MPM Capital manages $230M and $600M MPM BioVentures family of venture capital funds that are invested in selected private healthcare companies in the US and in Europe.
